Fundies. English
Segment disclosures
Company overviewImmuCell Corporation
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
5 dimension combinations 57 retained observations 15 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Corporate Segment Mastitis
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iccc:CorporateSegmentMastitisMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 75344 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 124864 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 49520 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 196388 | USD | 20260330 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 61503 | USD | 20251113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 146554 | USD | 20251113 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 46363 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 85051 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38688 | USD | 20260514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 178918 | USD | 20260330 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 60229 | USD | 20251113 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 139986 | USD | 20251113 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 177736 | USD | 20251113 | Open filing evidence |
Operating Segments · Corporate Segment Scours
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=iccc:CorporateSegmentScoursMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 7110769 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 17418544 | USD | 20260813 | Open filing evidence |
| 2026-01-01 – 2026-03-31 | 10307775 | USD | 20260514 | Open filing evidence |
| 2025-01-01 – 2025-12-31 | 27447786 | USD | 20260330 | Open filing evidence |
| 2025-07-01 – 2025-09-30 | 5444619 | USD | 20251113 | Open filing evidence |
| 2025-01-01 – 2025-09-30 | 19871621 | USD | 20251113 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 6398517 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14427003 | USD | 20260813 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8028486 | USD | 20260514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 26314251 | USD | 20260330 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 5951344 | USD | 20251113 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 18602054 | USD | 20251113 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 17293933 | USD | 20251113 | Open filing evidence |
Mastitis
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iccc:MastitisMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 46363 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 85051 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 38688 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 178918 | USD | 20250328 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 42821 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 79757 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 36936 | USD | 20250514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 177736 | USD | 20250328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 36437 | USD | 20231113 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 122153 | USD | 20231113 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 154558 | USD | 20240401 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 44976 | USD | 20231113 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 118237 | USD | 20231113 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 143280 | USD | 20231113 | Open filing evidence |
Scours
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=iccc:ScoursMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-04-01 – 2025-06-30 | 6398517 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 14427003 | USD | 20250814 | Open filing evidence |
| 2025-01-01 – 2025-03-31 | 8028486 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 26314251 | USD | 20250328 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 5430069 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 12650710 | USD | 20250814 | Open filing evidence |
| 2024-01-01 – 2024-03-31 | 7220641 | USD | 20250514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 17293933 | USD | 20250328 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 5360063 | USD | 20231113 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 12253555 | USD | 20231113 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 18411949 | USD | 20240401 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 4751049 | USD | 20231113 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14537390 | USD | 20231113 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 18933092 | USD | 20231113 | Open filing evidence |
All Other Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 1455 | USD | 20240401 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1455 | USD | 20231113 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 166597 | USD | 20231113 | Open filing evidence |